Literature DB >> 18544794

Building clinical capacity for fetal alcohol spectrum disorder diagnoses in western and northern Canada.

Sterling K Clarren1, Jan Lutke.   

Abstract

BACKGROUND: Fetal alcohol syndrome and fetal alcohol spectrum disorder are common problems. In response to this problem the Canada Northwest FASD Research Network was established in 2005 by the Canada Northwest FASD Ministerial Partnership. This study was conducted to determine the FASD clinical activity in Canada Northwest.
METHODS: The Network identified all clinical programs via Internet sites, provincial postings and professional word of mouth references that purported to do FASD assessments regularly using a multidisciplinary assessment team. Each of these programs was sent a questionnaire asking about clinical capacity, aggregate diagnostic results, team composition, time of clinical assessment and cost of assessment.
RESULTS: Of the 27 programs identified to receive the questionnaire 15 programs responded. These programs were determined to have evaluated about 85% of the patients evaluated by all the programs. The total 7 jurisdictional capacity for FASD diagnosis was 816 evaluations in 2005 and projected to be 975 in 2006. Selection methods for appointing patients for assessment seemed excellent as 23% of those assessed were found to have FAS or pFAS and another 44% had other forms of FASD. The most common professionals to participate in the team evaluations were Paediatricians, Clinical Psychologists, Speech and Language Pathologists and Occupational Therapists.
INTERPRETATION: Clinics are developing in western and northern Canada to diagnose patients with FASD. Comparing the experiences of these clinics can help to determine the continued need to increase diagnostic capacity, standardize diagnostic approaches to assure consistency of approach and diagnosis across the sites and appropriately staff and fund the programs. Key words: FASD; diagnosis; Canada; clinics.

Entities:  

Mesh:

Year:  2008        PMID: 18544794

Source DB:  PubMed          Journal:  Can J Clin Pharmacol        ISSN: 1198-581X


  9 in total

1.  Diagnosing fetal alcohol spectrum disorder: History, challenges and future directions.

Authors:  Jennifer Benz; Carmen Rasmussen; Gail Andrew
Journal:  Paediatr Child Health       Date:  2009-04       Impact factor: 2.253

2.  Maternal choline supplementation mitigates alcohol-induced fetal cranio-facial abnormalities detected using an ultrasonographic examination in a sheep model.

Authors:  Onkar B Sawant; Sharla M Birch; Charles R Goodlett; Timothy A Cudd; Shannon E Washburn
Journal:  Alcohol       Date:  2019-05-10       Impact factor: 2.405

3.  Primary visual response (M100) delays in adolescents with FASD as measured with MEG.

Authors:  Brian A Coffman; Piyadasa Kodituwakku; Elizabeth L Kodituwakku; Lucinda Romero; Nirupama Muniswamy Sharadamma; David Stone; Julia M Stephen
Journal:  Hum Brain Mapp       Date:  2012-06-05       Impact factor: 5.038

4.  Perceptions of Fetal Alcohol Spectrum Disorder (FASD) at a Mental Health Outpatient Treatment Provider in Minnesota.

Authors:  Jerrod Brown; Diane Harr
Journal:  Int J Environ Res Public Health       Date:  2018-12-21       Impact factor: 3.390

5.  Canadian clinical capacity for fetal alcohol spectrum disorder assessment, diagnosis, disclosure and support to children and adolescents: a cross-sectional study.

Authors:  Erika N Dugas; Martine Poirier; Dominique Basque; Nadia Bouhamdani; Laure LeBreton; Nicole Leblanc
Journal:  BMJ Open       Date:  2022-08-30       Impact factor: 3.006

6.  Cost of fetal alcohol spectrum disorder diagnosis in Canada.

Authors:  Svetlana Popova; Shannon Lange; Larry Burd; Albert E Chudley; Sterling K Clarren; Jürgen Rehm
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

7.  A modified Delphi study of screening for fetal alcohol spectrum disorders in Australia.

Authors:  Rochelle E Watkins; Elizabeth J Elliott; Jane Halliday; Colleen M O'Leary; Heather D'Antoine; Elizabeth Russell; Lorian Hayes; Elizabeth Peadon; Amanda Wilkins; Heather M Jones; Anne McKenzie; Sue Miers; Lucinda Burns; Raewyn C Mutch; Janet M Payne; James P Fitzpatrick; Maureen Carter; Jane Latimer; Carol Bower
Journal:  BMC Pediatr       Date:  2013-01-25       Impact factor: 2.125

8.  Construct and factorial validity of Neurobehavioral Disorder associated with Prenatal Alcohol Exposure (ND-PAE).

Authors:  James Ladell Sanders; Nicole Netelenbos; Samuel Ofori Dei
Journal:  BMC Psychol       Date:  2020-05-27

9.  The cost-effectiveness of screening tools used in the diagnosis of fetal alcohol spectrum disorder: a modelled analysis.

Authors:  Patrick Berrigan; Gail Andrew; James N Reynolds; Jennifer D Zwicker
Journal:  BMC Public Health       Date:  2019-12-27       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.